Effect of Sildenafil on Endothelial Function
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2005 by Rambam Health Care Campus.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Rambam Health Care Campus
Collaborator:
Pfizer
Information provided by:
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT00297544
First received: February 27, 2006
Last updated: NA
Last verified: November 2005
History: No changes posted
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | February 27, 2006 | ||||||||
| Last Updated Date | February 27, 2006 | ||||||||
| Start Date ICMJE | October 2005 | ||||||||
| Primary Completion Date | Not Provided | ||||||||
| Current Primary Outcome Measures ICMJE |
Improvement of endothelial function following Viagra treatment, according to platismographia. | ||||||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||||||
| Change History | No Changes Posted | ||||||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Effect of Sildenafil on Endothelial Function | ||||||||
| Official Title ICMJE | Effect of Sildenafil on Endothelial Function | ||||||||
| Brief Summary | We are investigating the chronic effect of daily assumption of Viagra on the blood vessels function in patients with impotence. The study will include 2 groups: 1- patients with multiple risk factors, e.g. hypertension 2- patients with no cardiovascular risk factors |
||||||||
| Detailed Description | We are investigating the chronic effect of daily assumption of Viagra on the blood vessels function in patients with impotence. The study will include 2 groups: 1- patients with multiple risk factors, e.g. hypertension 2- patients with no cardiovascular risk factors |
||||||||
| Study Type ICMJE | Interventional | ||||||||
| Study Phase | Not Provided | ||||||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Educational/Counseling/Training |
||||||||
| Condition ICMJE | Impotence | ||||||||
| Intervention ICMJE | Drug: Viagra | ||||||||
| Study Arm (s) | Not Provided | ||||||||
| Publications * |
|
||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Recruiting | ||||||||
| Enrollment ICMJE | 60 | ||||||||
| Completion Date | Not Provided | ||||||||
| Primary Completion Date | Not Provided | ||||||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||||
| Gender | Male | ||||||||
| Ages | 40 Years to 70 Years | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE |
|
||||||||
| Location Countries ICMJE | Israel | ||||||||
| Administrative Information | |||||||||
| NCT Number ICMJE | NCT00297544 | ||||||||
| Other Study ID Numbers ICMJE | 1777-CTIL | ||||||||
| Has Data Monitoring Committee | Not Provided | ||||||||
| Responsible Party | Not Provided | ||||||||
| Study Sponsor ICMJE | Rambam Health Care Campus | ||||||||
| Collaborators ICMJE | Pfizer | ||||||||
| Investigators ICMJE |
|
||||||||
| Information Provided By | Rambam Health Care Campus | ||||||||
| Verification Date | November 2005 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||